Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Clinical trial NCT01006369 · COMPLETED
Trial details
- NCT number
- NCT01006369
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2015-08-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.